Wednesday, 2 October 2019 | 09:00-11:00 | Kursaal C
Citizens and patients play a central role in cancer - in prevention, timely diagnosis and appropriate navigation, treatment, survivorship and decision-making to stop treatment at the end of life to preserve the quality of life.
At the same time, new technologies such as biomarker testing, public health genomics and "digital twins" hold a lot of promises to improve cancer outcomes for patients. However, new research shows that there is minimal awareness of health literacy in national cancer plans across Europe. Hence, how should patients and their relatives prepare for these challenges and opportunities? And how are providers and organisations responding? This session will feature experiences of patients and healthcare providers and outline how a stronger voice and engagement in co-production of solutions by citizens and patients could disrupt cancer care.